Since ADQ showed a sufficient reduction of Twist1 at 5 μM in our study, this suggests that ADQ is efficient in suppressing Twist1 levels and can be developed as a drug candidate for treating multiple cancer types. The gene discussed is TWIST1; the disease is cancer.